Deversify closes SEK 2M in financing, gets ready to launch its first mobile healthcare product in 2018.
Deversify, an Uppsala, Sweden-based startup that is working on manufacturing mobile products for healthcare industry, announced closing a SEK 2M ($240k) investment round. Most of the money comes from its existing investor and will be used to launch of their product, the Acetrack keter meter, in the first quarter of 2018.
Deversify, founded in 2016 and led by CEO Anders Murman, focuses on product development of both devices and software applications within the mobile health (mHealth) industry. Their main business idea is to identify good innovation ideas within mHealth, build a business case around the idea, develop and design one or many prototypes showing the potential of the idea, and finally license the product solution to market-oriented vendors, i.e. a model of product licensing purely business-to-business. These new products are offered to companies within the life science and IT business segments. The end products may equally be intended for professional medical use as well as by individual consumers.
The first product of the company is Acetrack, a solution for monitoring metabolism in connection with ketogen diets, aimed primarily directly to the consumers market.